Even after a treatment has received regulatory approval, continuous monitoring is essential. Post-market surveillance involves tracking the treatment's performance in the real world to identify any long-term side effects or issues that were not apparent during clinical trials. This ongoing evaluation helps ensure the continued safety and efficacy of cancer treatments.
